BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Grunewald J, Grutters JC, Arkema EV, Saketkoo LA, Moller DR, Müller-Quernheim J. Sarcoidosis. Nat Rev Dis Primers 2019;5:45. [PMID: 31273209 DOI: 10.1038/s41572-019-0096-x] [Cited by in Crossref: 91] [Cited by in F6Publishing: 71] [Article Influence: 30.3] [Reference Citation Analysis]
Number Citing Articles
1 Tsiakos K, Zoupas I, Vamvakaris I, Poulakou G, Syrigos K, Chatzis L. Primary Sarcoidosis of the Adipose Tissue: A New Variant of Sarcoidosis. Mayo Clin Proc 2022;97:1403-5. [PMID: 35787872 DOI: 10.1016/j.mayocp.2022.05.016] [Reference Citation Analysis]
2 Soriano D, Quartucci C, Agarwal P, Müller-quernheim J, Frye BC. Sarkoidose und Berylliose. Internist. [DOI: 10.1007/s00108-022-01323-x] [Reference Citation Analysis]
3 Liu A, Sharma L, Yan X, Dela Cruz CS, Herzog EL, Ryu C. Emerging insights in sarcoidosis: moving forward through reverse translational research. Am J Physiol Lung Cell Mol Physiol 2022. [PMID: 35196896 DOI: 10.1152/ajplung.00266.2021] [Reference Citation Analysis]
4 Kahlmann V, Manansala M, Moor CC, Shahrara S, Wijsenbeek MS, Sweiss NJ. COVID-19 infection in patients with sarcoidosis: susceptibility and clinical outcomes. Curr Opin Pulm Med 2021;27:463-71. [PMID: 34397613 DOI: 10.1097/MCP.0000000000000812] [Reference Citation Analysis]
5 Rutkowska E, Kwiecień I, Bednarek J, Sokołowski R, Raniszewska A, Jahnz-Różyk K, Rzepecki P. T Lymphocyte Maturation Profile in the EBUS-TBNA Lymph Node Depending on the DLCO Parameter in Patients with Pulmonary Sarcoidosis. Cells 2021;10:3404. [PMID: 34943912 DOI: 10.3390/cells10123404] [Reference Citation Analysis]
6 Rossides M, Kullberg S, Askling J, Eklund A, Grunewald J, Di Giuseppe D, Arkema EV. Are infectious diseases risk factors for sarcoidosis or a result of reverse causation? Findings from a population-based nested case-control study. Eur J Epidemiol 2020;35:1087-97. [PMID: 32048110 DOI: 10.1007/s10654-020-00611-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
7 Grieco T, Rossi A, Maddalena P, Sernicola A, Ambrosio L, Fino P, Gomes V. COVID-19 infection and BNT162b2 vaccine triggering sarcoid-like lesions in the same patient. Response to: Sarcoid-like reaction in a patient recovering from COVID-19 pneumonia. JAAD Case Rep 2022;23:162-3. [PMID: 35079616 DOI: 10.1016/j.jdcr.2021.12.042] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Anastasopoulou A, Diamantopoulos PT, Skalioti C, Liapis G, Psychogiou E, Ziogas DC, Gogas H. The diagnosis and management of sarcoid-like reactions in patients with melanoma treated with BRAF and MEK inhibitors. A case series and review of the literature. Ther Adv Med Oncol 2021;13:17588359211047349. [PMID: 34691245 DOI: 10.1177/17588359211047349] [Reference Citation Analysis]
9 Borba V, Malkova A, Basantsova N, Halpert G, Andreoli L, Tincani A, Amital H, Shoenfeld Y. Classical Examples of the Concept of the ASIA Syndrome. Biomolecules 2020;10:E1436. [PMID: 33053910 DOI: 10.3390/biom10101436] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
10 Courtin E, Ouallet J, Lazaro E, Martin-negrier M, Cohen-aubart F, Duffau P. Isolated CNS Sarcoidosis Versus Systemic Sarcoidosis With CNS Involvement: A Same Disease? The Neurohospitalist. [DOI: 10.1177/19418744211030416] [Reference Citation Analysis]
11 Drake WP, Culver DA, Baughman RP, Judson MA, Crouser ED, James WE, Ayers GD, Ding T, Abel K, Green A, Kerrigan A, Sesay A, Bernard GR. Phase II Investigation of the Efficacy of Antimycobacterial Therapy in Chronic Pulmonary Sarcoidosis. Chest 2021;159:1902-12. [PMID: 33387486 DOI: 10.1016/j.chest.2020.12.027] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Brito-Zerón P, Pérez-Álvarez R, Ramos-Casals M. Sarcoidosis. Med Clin (Barc) 2022:S0025-7753(22)00178-6. [PMID: 35680449 DOI: 10.1016/j.medcli.2022.03.009] [Reference Citation Analysis]
13 Sikjær MG, Hilberg O, Ibsen R, Løkke A. Sarcoidosis: A nationwide registry-based study of incidence, prevalence and diagnostic work-up. Respir Med 2021;187:106548. [PMID: 34352562 DOI: 10.1016/j.rmed.2021.106548] [Reference Citation Analysis]
14 Drent M, Proesmans VLJ, Elfferich MDP, Jessurun NT, de Jong SMG, Ebner NM, Lewis EDO, Bast A. Ranking Self-reported Gastrointestinal Side Effects of Pharmacotherapy in Sarcoidosis. Lung 2020;198:395-403. [PMID: 31960165 DOI: 10.1007/s00408-020-00323-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
15 Sesé L, Jeny F, Uzunhan Y, Khamis W, Freynet O, Valeyre D, Bernaudin JF, Annesi-Maesano I, Nunes H. [The effect of air pollution in diffuse interstitial lung disease]. Rev Mal Respir 2020;37:389-98. [PMID: 32278507 DOI: 10.1016/j.rmr.2020.02.015] [Reference Citation Analysis]
16 Wu JH, Imadojemu S, Caplan AS. The Evolving Landscape of Cutaneous Sarcoidosis: Pathogenic Insight, Clinical Challenges, and New Frontiers in Therapy. Am J Clin Dermatol 2022. [PMID: 35583850 DOI: 10.1007/s40257-022-00693-0] [Reference Citation Analysis]
17 Bagavant H, Cizio K, Araszkiewicz AM, Papinska JA, Garman L, Li C, Pezant N, Drake WP, Montgomery CG, Deshmukh US. Systemic immune response to vimentin and granuloma formation in a model of pulmonary sarcoidosis. Journal of Translational Autoimmunity 2022;5:100153. [DOI: 10.1016/j.jtauto.2022.100153] [Reference Citation Analysis]
18 Vanessa F, Frediano I, Luca Z. Diagnosis of sarcoidosis in a patient with differentiated thyroid cancer and sudden rise of anti-thyroglobulin antibodies during follow-up. Endocrine 2021;73:487-90. [PMID: 33599943 DOI: 10.1007/s12020-021-02613-4] [Reference Citation Analysis]
19 Feng H, Yan L, Zhao Y, Li Z, Kang J. Neutrophils in Bronchoalveolar Lavage Fluid Indicating the Severity and Relapse of Pulmonary Sarcoidosis. Front Med (Lausanne) 2021;8:787681. [PMID: 35186971 DOI: 10.3389/fmed.2021.787681] [Reference Citation Analysis]
20 Dehara M, Sachs MC, Kullberg S, Grunewald J, Blomberg A, Arkema EV. Reproductive and hormonal risk factors for sarcoidosis: a nested case–control study. BMC Pulm Med 2022;22. [DOI: 10.1186/s12890-022-01834-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
21 Kidd DP. Neurosarcoidosis: clinical manifestations, investigation and treatment. Pract Neurol 2020;20:199-212. [PMID: 32424017 DOI: 10.1136/practneurol-2019-002349] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
22 Miedema JR, Bonella F, Grunewald J, Spagnolo P. Looking into the future of sarcoidosis: what is next for treatment? Current Opinion in Pulmonary Medicine 2020;26:598-607. [DOI: 10.1097/mcp.0000000000000709] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
23 Cheung E, Ahmad S, Aitken M, Chan R, Iwanochko RM, Balter M, Metser U, Veit-Haibach P, Billia F, Moayedi Y, Ross HJ, Hanneman K. Combined simultaneous FDG-PET/MRI with T1 and T2 mapping as an imaging biomarker for the diagnosis and prognosis of suspected cardiac sarcoidosis. Eur J Hybrid Imaging 2021;5:24. [PMID: 34913098 DOI: 10.1186/s41824-021-00119-w] [Reference Citation Analysis]
24 Voortman M, Stern BJ, Saketkoo LA, Drent M. The Burden of Neurosarcoidosis: Essential Approaches to Early Diagnosis and Treatment. Semin Respir Crit Care Med 2020;41:641-51. [PMID: 32777849 DOI: 10.1055/s-0040-1710576] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
25 Frye BC, Potasso L, Farin E, Fichtner U, Birring S, Müller-Quernheim J, Schupp JC. Abnormal FeV1 and body mass index are associated with impaired cough-related quality of life in sarcoidosis patients. Respir Med 2021;188:106600. [PMID: 34530353 DOI: 10.1016/j.rmed.2021.106600] [Reference Citation Analysis]
26 Jeny F, Bernaudin JF, Valeyre D, Nunes H, Planès C, Besnard V. [Is hypoxia a factor in the progression of pulmonary sarcoidosis?]. Rev Mal Respir 2020;37:214-7. [PMID: 32146058 DOI: 10.1016/j.rmr.2020.02.006] [Reference Citation Analysis]
27 Valeyre D, Bernaudin JF. Management of Sarcoidosis, a Selection of Topical Items Updating. J Clin Med 2020;9:E3220. [PMID: 33036457 DOI: 10.3390/jcm9103220] [Reference Citation Analysis]
28 Patterson KC, Rosenbach M, Bravo PE, Dubroff JG. Stable Extent of Recurrently Active Cardiac and Cutaneous Sarcoidosis. Front Med (Lausanne) 2021;8:729229. [PMID: 34926489 DOI: 10.3389/fmed.2021.729229] [Reference Citation Analysis]
29 Sugimoto H, Takeuchi M, Taniguchi Y, Sato J. Sudden Cardiac Arrest in a Patient With Sarcoidosis and Familial Hypercholesterolemia. Cureus 2021;13:e13649. [PMID: 33824802 DOI: 10.7759/cureus.13649] [Reference Citation Analysis]
30 Dawkins BA, Garman L, Cejda N, Pezant N, Rasmussen A, Rybicki BA, Levin AM, Benchek P, Seshadri C, Mayanja-Kizza H, Iannuzzi MC, Stein CM, Montgomery CG. Novel HLA associations with outcomes of Mycobacterium tuberculosis exposure and sarcoidosis in individuals of African ancestry using nearest-neighbor feature selection. Genet Epidemiol 2022. [PMID: 35702824 DOI: 10.1002/gepi.22490] [Reference Citation Analysis]
31 Bonifazi M, Renzoni EA, Lower EE. Sarcoidosis and maligancy: the chicken and the egg? Curr Opin Pulm Med 2021;27:455-62. [PMID: 34231536 DOI: 10.1097/MCP.0000000000000806] [Reference Citation Analysis]
32 Caplan A, Rosenbach M, Imadojemu S. Cutaneous Sarcoidosis. Semin Respir Crit Care Med 2020;41:689-99. [PMID: 32593176 DOI: 10.1055/s-0040-1713130] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
33 Li B, Lento PA, Pan S. Inflammatory Cardiomyopathy: Case-based Review on Clinical Presentation, Diagnosis, and Management. Cardiol Rev 2021;29:230-7. [PMID: 33165090 DOI: 10.1097/CRD.0000000000000369] [Reference Citation Analysis]
34 Schrijver B, Kolijn PM, Ten Berge JCEM, Nagtzaam NMA, van Rijswijk ALCT, Swagemakers SMA, van der Spek PJ, Missotten TOAR, van Velthoven MEJ, de Hoog J, van Hagen PM, Langerak AW, Dik WA. Vitreous proteomics, a gateway to improved understanding and stratification of diverse uveitis aetiologies. Acta Ophthalmol 2022;100:403-13. [PMID: 34318583 DOI: 10.1111/aos.14993] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Iriarte A, Rubio-Rivas M, Villalba N, Corbella X, Mañá J. Clinical features and outcomes of asymptomatic pulmonary sarcoidosis. A comparative cohort study. Respir Med 2020;169:105998. [PMID: 32442109 DOI: 10.1016/j.rmed.2020.105998] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Switlyk MD, Niehusmann P, Sprauten M, Magelssen H, Aarhus M, Rasmussen FØ, Knutstad K, Brandal P. Neurosarcoidosis resembling multiple meningiomas: A misleading presentation of the disease and diagnostic challenge. Acta Radiol Open 2021;10:20584601211036550. [PMID: 34377543 DOI: 10.1177/20584601211036550] [Reference Citation Analysis]
37 Kullberg S, Rivera NV, Abo Al Hayja M, Grunewald J, Eklund A. Changes in lung immune cells related to clinical outcome during treatment with infliximab for sarcoidosis. Clin Exp Immunol 2020;201:85-93. [PMID: 32275772 DOI: 10.1111/cei.13438] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
38 Rossides M, Kullberg S, Grunewald J, Eklund A, Di Giuseppe D, Askling J, Arkema EV. Risk of acute myocardial infarction in sarcoidosis: A population-based cohort study from Sweden. Respir Med 2021;188:106624. [PMID: 34583304 DOI: 10.1016/j.rmed.2021.106624] [Reference Citation Analysis]
39 Lundkvist A, Kullberg S, Arkema EV, Cedelund K, Eklund A, Grunewald J, Darlington P. Differences in disease presentation between men and women with sarcoidosis: A cohort study. Respir Med 2021;191:106688. [PMID: 34839065 DOI: 10.1016/j.rmed.2021.106688] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Lepzien R, Nie M, Czarnewski P, Liu S, Yu M, Ravindran A, Kullberg S, Eklund A, Grunewald J, Smed-Sörensen A. Pulmonary and blood dendritic cells from sarcoidosis patients more potently induce IFNγ-producing Th1 cells compared with monocytes. J Leukoc Biol 2021. [PMID: 34431542 DOI: 10.1002/JLB.5A0321-162R] [Reference Citation Analysis]
41 Abo Al Hayja M, Wahlström J, Kullberg S, Darlington P, Eklund A, Grunewald J. Bronchoalveolar lavage fluid cell subsets associate with the disease course in Löfgren's and non-Löfgren's sarcoidosis patients. Respir Med 2021;186:106521. [PMID: 34198166 DOI: 10.1016/j.rmed.2021.106521] [Reference Citation Analysis]
42 Kim ST, Pundole X, Dadu R, Lambotte O, Ramos-Casals M, Suarez-Almazor ME. Use of immune checkpoint inhibitors in cancer patients with pre-existing sarcoidosis. Immunotherapy 2021;13:465-75. [PMID: 33641345 DOI: 10.2217/imt-2020-0272] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
43 Kontzias A, Barkhodari A, Yao Q. Pericarditis in Systemic Rheumatologic Diseases. Curr Cardiol Rep 2020;22:142. [PMID: 32910306 DOI: 10.1007/s11886-020-01415-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
44 d'Alessandro M, Bergantini L, Cameli P, Mezzasalma F, Refini RM, Pieroni M, Sestini P, Bargagli E. Adaptive immune system in pulmonary sarcoidosis-Comparison of peripheral and alveolar biomarkers. Clin Exp Immunol 2021;205:406-16. [PMID: 34107064 DOI: 10.1111/cei.13635] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
45 Rossides M, Kullberg S, Eklund A, Di Giuseppe D, Grunewald J, Askling J, Arkema EV. Risk of first and recurrent serious infection in sarcoidosis: a Swedish register-based cohort study. Eur Respir J 2020;56:2000767. [PMID: 32366492 DOI: 10.1183/13993003.00767-2020] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
46 Kolios AGA, Tsokos GC, Klatzmann D. Interleukin-2 and regulatory T cells in rheumatic diseases. Nat Rev Rheumatol 2021;17:749-66. [PMID: 34728817 DOI: 10.1038/s41584-021-00707-x] [Reference Citation Analysis]
47 Zhang S, Tong X, Zhang T, Wang D, Liu S, Wang L, Fan H. Prevalence of Sarcoidosis-Associated Pulmonary Hypertension: A Systematic Review and Meta-Analysis. Front Cardiovasc Med 2022;8:809594. [DOI: 10.3389/fcvm.2021.809594] [Reference Citation Analysis]
48 Aldea-Parés A, Alves AS, Vasconcelo Barros C, Boncoraglio MT, Redondo-Urda MJ, Sanfeliu E, Prieto-González S, Espinosa G. Unilateral granulomatous mastitis in a pregnant woman as a first manifestation of sarcoidosis. Scand J Rheumatol 2021;:1-3. [PMID: 33412962 DOI: 10.1080/03009742.2020.1846781] [Reference Citation Analysis]
49 Rossides M, Kullberg S, Grunewald J, Eklund A, Di Giuseppe D, Askling J, Arkema EV. Risk and predictors of heart failure in sarcoidosis in a population-based cohort study from Sweden. Heart 2021:heartjnl-2021-319129. [PMID: 34021039 DOI: 10.1136/heartjnl-2021-319129] [Reference Citation Analysis]
50 Kahlmann V, Janssen Bonás M, Moor CC, van Moorsel CHM, Kool M, Kraaijvanger R, Grutters JC, Overgaauw M, Veltkamp M, Wijsenbeek MS; Collaborating investigators. Design of a randomized controlled trial to evaluate effectiveness of methotrexate versus prednisone as first-line treatment for pulmonary sarcoidosis: the PREDMETH study. BMC Pulm Med 2020;20:271. [PMID: 33076885 DOI: 10.1186/s12890-020-01290-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
51 Moor CC, Kahlmann V, Culver DA, Wijsenbeek MS. Comprehensive Care for Patients with Sarcoidosis. J Clin Med 2020;9:E390. [PMID: 32024123 DOI: 10.3390/jcm9020390] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
52 Eldhagen P, Bobbio E, Darlington P, Grunewald J, Eklund A, Polte CL, Bergh N, Bollano E, Sörensson P, Kullberg S. Phenotypic and HLA-DRB1 allele characterization of Swedish cardiac sarcoidosis patients. Int J Cardiol 2022:S0167-5273(22)00485-5. [PMID: 35395284 DOI: 10.1016/j.ijcard.2022.04.006] [Reference Citation Analysis]
53 Bernardinello N, Petrarulo S, Balestro E, Cocconcelli E, Veltkamp M, Spagnolo P. Pulmonary Sarcoidosis: Diagnosis and Differential Diagnosis. Diagnostics (Basel) 2021;11:1558. [PMID: 34573900 DOI: 10.3390/diagnostics11091558] [Reference Citation Analysis]
54 Shchepikhin EI, Shmelev EI, Zaytseva AS. Respiratory diseases and obesity: special phenotype or independent events: Review. Terapevticheskii arkhiv 2022;94:442-7. [DOI: 10.26442/00403660.2022.03.201412] [Reference Citation Analysis]
55 Kotetsu Y, Yanagihara T, Suzuki K, Ando H, Eto D, Hata K, Arimura-Omori M, Yamamoto Y, Harada E, Hamada N. Imaging Changes and Immune-Checkpoint Expression on T Cells in Bronchoalveolar Lavage Fluid from Patients with Pulmonary Sarcoidosis. Biomedicines 2021;9:1231. [PMID: 34572417 DOI: 10.3390/biomedicines9091231] [Reference Citation Analysis]
56 Lee S, Birnie D, Dwivedi G. Current perspectives on the immunopathogenesis of sarcoidosis. Respir Med 2020;173:106161. [PMID: 32992264 DOI: 10.1016/j.rmed.2020.106161] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
57 Wurm-Kuczera RI, Buentzel J, Koenig JFL, Legler T, Valk JJ, Hasenkamp J, Jung W, Rademacher JG, Korsten P, Wulf GG. Sarcoidosis Following Hematopoietic Stem Cell Transplantation: Clinical Characteristics and HLA Associations. Front Immunol 2021;12:746996. [PMID: 34691055 DOI: 10.3389/fimmu.2021.746996] [Reference Citation Analysis]
58 Garneret E, Jamilloux Y, Gerfaud-Valentin M, Kodjikian L, Trad S, Sève P. Prevalence of Positive QuantiFERON-TB Test among Sarcoid Uveitis Patients and its Clinical Implications in a Country Non-endemic for Tuberculosis. Ocul Immunol Inflamm 2022;:1-9. [PMID: 35797278 DOI: 10.1080/09273948.2022.2073238] [Reference Citation Analysis]
59 Entrop JP, Kullberg S, Grunewald J, Eklund A, Brismar K, Arkema EV. Type 2 diabetes risk in sarcoidosis patients untreated and treated with corticosteroids. ERJ Open Res 2021;7:00028-2021. [PMID: 34046487 DOI: 10.1183/23120541.00028-2021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
60 Sano Y, Fujiwara M, Yuasa T, Komai Y, Yamamoto T, Kohno A, Nakao M, Inamura K, Yonese J. Testicular seminoma with a progressing pulmonary nodule and mediastinal lymphadenopathy without retroperitoneal metastasis. IJU Case Rep 2020;3:211-4. [PMID: 32914079 DOI: 10.1002/iju5.12191] [Reference Citation Analysis]
61 Di Francesco AM, Verrecchia E, Sicignano LL, Massaro MG, Antuzzi D, Covino M, Pasciuto G, Richeldi L, Manna R. The Use of Chitotriosidase as a Marker of Active Sarcoidosis and in the Diagnosis of Fever of Unknown Origin (FUO). J Clin Med 2021;10:5283. [PMID: 34830565 DOI: 10.3390/jcm10225283] [Reference Citation Analysis]
62 Alawi F, Shields BE, Omolehinwa T, Rosenbach M. Oral Granulomatous Disease. Dermatol Clin 2020;38:429-39. [PMID: 32892852 DOI: 10.1016/j.det.2020.05.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
63 Zhang H, Costabel U, Dai H. The Role of Diverse Immune Cells in Sarcoidosis. Front Immunol 2021;12:788502. [PMID: 34868074 DOI: 10.3389/fimmu.2021.788502] [Reference Citation Analysis]
64 Vagts C, Ascoli C, Fraidenburg DR, Baughman RP, Huang Y, Edafetanure-Ibeh R, Ahmed S, Levin B, Lu Y, Perkins DL, Finn PW, Sweiss NJ. Unsupervised Clustering Reveals Sarcoidosis Phenotypes Marked by a Reduction in Lymphocytes Relate to Increased Inflammatory Activity on 18FDG-PET/CT. Front Med (Lausanne) 2021;8:595077. [PMID: 33718397 DOI: 10.3389/fmed.2021.595077] [Reference Citation Analysis]
65 Calender A, Weichhart T, Valeyre D, Pacheco Y. Current Insights in Genetics of Sarcoidosis: Functional and Clinical Impacts. J Clin Med 2020;9:E2633. [PMID: 32823753 DOI: 10.3390/jcm9082633] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
66 Besnard V, Jeny F. Models Contribution to the Understanding of Sarcoidosis Pathogenesis: "Are There Good Models of Sarcoidosis?". J Clin Med 2020;9:E2445. [PMID: 32751786 DOI: 10.3390/jcm9082445] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
67 Mousapasandi A, Herbert C, Thomas P. Potential use of biomarkers for the clinical evaluation of sarcoidosis. J Investig Med 2021:jim-2020-001659. [PMID: 33452128 DOI: 10.1136/jim-2020-001659] [Reference Citation Analysis]
68 Ceder S, Rossides M, Kullberg S, Eklund A, Grunewald J, Arkema EV. Positive Predictive Value of Sarcoidosis Identified in an Administrative Healthcare Registry: A Validation Study. Epidemiology 2021;32:444-7. [PMID: 33625159 DOI: 10.1097/EDE.0000000000001323] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
69 Frye BC, Rump IC, Uhlmann A, Schubach F, Ihorst G, Grimbacher B, Zissel G, Quernheim JM. Safety and efficacy of abatacept in patients with treatment-resistant SARCoidosis (ABASARC) - protocol for a multi-center, single-arm phase IIa trial. Contemp Clin Trials Commun 2020;19:100575. [PMID: 32551397 DOI: 10.1016/j.conctc.2020.100575] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
70 Sweiss NJ, Korsten P, Syed HJ, Syed A, Baughman RP, Yee AMF, Culver DA, Sosenko T, Azuma A, Bonella F, Costabel U, Drake WP, Drent M, Lower EE, Israel-Biet D, Mostard RLM, Nunes H, Rottoli P, Spagnolo P, Wells AU, Wuyts WA, Judson MA. When the Game Changes: Guidance to Adjust Sarcoidosis Management During the Coronavirus Disease 2019 Pandemic. Chest 2020;158:892-5. [PMID: 32360495 DOI: 10.1016/j.chest.2020.04.033] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 10.0] [Reference Citation Analysis]
71 Bhargava M, Mroz MM, Maier LA. Smoke Signals: Promise of Nicotine as a Treatment for Pulmonary Sarcoidosis. Chest 2021;160:1169-70. [PMID: 34625164 DOI: 10.1016/j.chest.2021.06.051] [Reference Citation Analysis]
72 Papiris SA, Manali ED, Papaioannou AI, Georgakopoulos A, Kolilekas L, Pianou NK, Kallergi M, Papaporfyriou A, Kallieri M, Apollonatou V, Papadaki G, Malagari K, Kelekis NL, Pneumatikos SG, Chatziioannou S. Prevalence, distribution and clinical significance of joints, muscles and bones in sarcoidosis: an 18F-FDG-PET/CT study. Expert Rev Respir Med 2020;14:957-64. [PMID: 32460642 DOI: 10.1080/17476348.2020.1775587] [Reference Citation Analysis]
73 Valeyre D, Jeny F, Rotenberg C, Bouvry D, Uzunhan Y, Sève P, Nunes H, Bernaudin JF. How to Tackle the Diagnosis and Treatment in the Diverse Scenarios of Extrapulmonary Sarcoidosis. Adv Ther 2021;38:4605-27. [PMID: 34296400 DOI: 10.1007/s12325-021-01832-5] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
74 Kysperska K, Kuchynka P, Palecek T. Cardiac sarcoidosis: from diagnosis to treatment. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2021;165:347-59. [PMID: 34671170 DOI: 10.5507/bp.2021.057] [Reference Citation Analysis]
75 Kullberg S, Rivera NV, Grunewald J, Eklund A. Effects of infliximab on lung and circulating natural killer cells, CD56+ T cells and B cells in sarcoidosis. BMJ Open Respir Res 2021;8:e000933. [PMID: 34233893 DOI: 10.1136/bmjresp-2021-000933] [Reference Citation Analysis]
76 Zhang Q, Huang H, Zhang M, Fang C, Wang N, Jing X, Guo J, Sun W, Yang X, Xu Z. Exome Sequencing Reveals Genetic Variability and Identifies Chronic Prognostic Loci in Chinese Sarcoidosis Patients. Front Oncol 2022;12:910227. [DOI: 10.3389/fonc.2022.910227] [Reference Citation Analysis]
77 Lui JK, Mesfin N, Tugal D, Klings ES, Govender P, Berman JS. Critical Care of Patients With Cardiopulmonary Complications of Sarcoidosis. J Intensive Care Med 2021;:885066621993041. [PMID: 33611981 DOI: 10.1177/0885066621993041] [Reference Citation Analysis]
78 Pacheco Y, Valeyre D, El Jammal T, Vallee M, Chevalier F, Lamartine J, Sigaudo-Roussel D, Verrier B, Israel-Biet D, Freymond N, Cottin V, Calender A. Autophagy and Mitophagy-Related Pathways at the Crossroads of Genetic Pathways Involved in Familial Sarcoidosis and Host-Pathogen Interactions Induced by Coronaviruses. Cells 2021;10:1995. [PMID: 34440765 DOI: 10.3390/cells10081995] [Reference Citation Analysis]
79 Riteau N, Bernaudin JF. In addition to mTOR and JAK/STAT, NLRP3 inflammasome is another key pathway activated in sarcoidosis. Eur Respir J 2020;55:2000149. [PMID: 32217622 DOI: 10.1183/13993003.00149-2020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
80 Paolino A, Galloway J, Birring S, Brex P, Larkin G, Patel A, Sado D, Murgatroyd F, Walsh S. Clinical phenotypes and therapeutic responses in cutaneous-predominant sarcoidosis: 6-year experience in a tertiary referral service. Clin Exp Dermatol 2021;46:1038-45. [PMID: 33608920 DOI: 10.1111/ced.14614] [Reference Citation Analysis]
81 Goto K, Uehara M, Okamoto K, Takeda N, Morita H, Hatano M, Komuro I. The therapeutic dilemma of immunosuppressive drugs for refractory cardiac sarcoidosis in COVID-19 infection. ESC Heart Fail 2021;8:5577-82. [PMID: 34697891 DOI: 10.1002/ehf2.13676] [Reference Citation Analysis]
82 Mirsaeidi M, Baughman RP. Repository Corticotropin Injection for the Treatment of Pulmonary Sarcoidosis: A Narrative Review. Pulm Ther 2022. [PMID: 35113366 DOI: 10.1007/s41030-022-00181-0] [Reference Citation Analysis]
83 Dievernich A, Achenbach P, Davies L, Klinge U. Characterization of innate and adaptive immune cells involved in the foreign body reaction to polypropylene meshes in the human abdomen. Hernia 2021. [PMID: 33788008 DOI: 10.1007/s10029-021-02396-7] [Reference Citation Analysis]
84 Trivieri MG, Spagnolo P, Birnie D, Liu P, Drake W, Kovacic JC, Baughman R, Fayad ZA, Judson MA. Challenges in Cardiac and Pulmonary Sarcoidosis: JACC State-of-the-Art Review. J Am Coll Cardiol 2020;76:1878-901. [PMID: 33059834 DOI: 10.1016/j.jacc.2020.08.042] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 18.0] [Reference Citation Analysis]
85 Alparslan Bekir S, Sonkaya E, Ozbaki F, Aydogan Eroglu S, Sertcelik L, Duman D, Kavas M, Agca M, Erdem I, Ozmen I, Boga S, Hazar A, Sevim T, Turker H, Tuncay E, Gungor S, Karakurt Z. The utility of neutrophil-to-lymphocyte ratio determined at initial diagnosis in predicting disease stage and discriminating between active and stable disease in patients with sarcoidosis: cross-sectional study. Postgrad Med 2022. [PMID: 35619233 DOI: 10.1080/00325481.2022.2082805] [Reference Citation Analysis]
86 Sharp M, Eakin MN, Drent M. Socioeconomic determinants and disparities in sarcoidosis. Curr Opin Pulm Med 2020;26:568-73. [PMID: 32732595 DOI: 10.1097/MCP.0000000000000704] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
87 Graff P, Larsson J, Bryngelsson IL, Wiebert P, Vihlborg P. Sarcoidosis and silica dust exposure among men in Sweden: a case-control study. BMJ Open 2020;10:e038926. [PMID: 32883739 DOI: 10.1136/bmjopen-2020-038926] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
88 Calatroni M, Moroni G, Reggiani F, Ponticelli C. Renal sarcoidosis. J Nephrol 2022. [PMID: 35761015 DOI: 10.1007/s40620-022-01369-y] [Reference Citation Analysis]
89 Calender A, Israel-Biet D, Valeyre D, Pacheco Y. Modeling Potential Autophagy Pathways in COVID-19 and Sarcoidosis. Trends Immunol 2020;41:856-9. [PMID: 32863134 DOI: 10.1016/j.it.2020.08.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
90 Parekh M, Balasubramanya R, Kumaran M, Donuru A. Intrathoracic Manifestations of Sarcoidosis: an Imaging Review Highlighting Atypical Features. Curr Pulmonol Rep 2020;9:74-81. [DOI: 10.1007/s13665-020-00255-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
91 Miedema J, Nunes H. Drug-induced sarcoidosis-like reactions. Curr Opin Pulm Med 2021;27:439-47. [PMID: 34183524 DOI: 10.1097/MCP.0000000000000800] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
92 Bernard-Valnet R, Perriot S, Canales M, Pizzarotti B, Caranzano L, Castro-Jiménez M, Epiney JB, Vijiala S, Salvioni-Chiabotti P, Anichini A, Salerno A, Jaton K, Vaucher J, Perreau M, Greub G, Pantaleo G, Du Pasquier RA. Encephalopathies Associated With Severe COVID-19 Present Neurovascular Unit Alterations Without Evidence for Strong Neuroinflammation. Neurol Neuroimmunol Neuroinflamm 2021;8:e1029. [PMID: 34135107 DOI: 10.1212/NXI.0000000000001029] [Reference Citation Analysis]
93 Bode SFN, Rohr J, Müller Quernheim J, Seidl M, Speckmann C, Heinzmann A. Pulmonary granulomatosis of genetic origin. Eur Respir Rev 2021;30:200152. [PMID: 33927005 DOI: 10.1183/16000617.0152-2020] [Reference Citation Analysis]
94 Jain R, Yadav D, Puranik N, Guleria R, Jin JO. Sarcoidosis: Causes, Diagnosis, Clinical Features, and Treatments. J Clin Med 2020;9:E1081. [PMID: 32290254 DOI: 10.3390/jcm9041081] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 8.5] [Reference Citation Analysis]
95 Buelens T, Scifo L, Valyi Z, Willermain F. Sarcoidosis revealed by simultaneous optic nerve and eyelid involvement: A case report. American Journal of Ophthalmology Case Reports 2022;26:101451. [DOI: 10.1016/j.ajoc.2022.101451] [Reference Citation Analysis]
96 Sahin Tekin M, Kocaturk E, Gurcu S, Kayadibi H, Dibeklioglu B, Yorulmaz G. Cellular Immunity In Subacute Thyroiditis: A New Perspective Through Neopterin. Clin Exp Immunol 2022:uxac050. [PMID: 35576515 DOI: 10.1093/cei/uxac050] [Reference Citation Analysis]
97 Otto C, Wengert O, Unterwalder N, Meisel C, Ruprecht K. Analysis of soluble interleukin-2 receptor as CSF biomarker for neurosarcoidosis. Neurol Neuroimmunol Neuroinflamm 2020;7:e725. [PMID: 32393650 DOI: 10.1212/NXI.0000000000000725] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
98 Jarvela J, Moyer M, Leahy P, Bonfield T, Fletcher D, Mkono WN, Aung H, Canaday DH, Dazard JE, Silver RF. Mycobacterium tuberculosis-Induced Bronchoalveolar Lavage Gene Expression Signature in Latent Tuberculosis Infection Is Dominated by Pleiotropic Effects of CD4+ T Cell-Dependent IFN-γ Production despite the Presence of Polyfunctional T Cells within the Airways. J Immunol 2019;203:2194-209. [PMID: 31541022 DOI: 10.4049/jimmunol.1900230] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
99 Somani SN, Schneider AL, Welch KC, Alexiev BA, Matsuoka AJ. Probable neurosarcoidosis presenting as acute on chronic otorrhoea: a difficult diagnosis. BMJ Case Rep 2020;13:e237676. [PMID: 33139371 DOI: 10.1136/bcr-2020-237676] [Reference Citation Analysis]
100 Keukeleire S, Schwarze J, Awada G, Everaert H, Van Binst AM, Cras L, Neyns B, Aspeslagh S. An atypical sarcoid-like reaction during anti-protein death 1 treatment in a patient with metastatic melanoma. Melanoma Res 2020;30:524-7. [PMID: 32898392 DOI: 10.1097/CMR.0000000000000680] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
101 Sawahata M, Sakamoto N, Yamasawa H, Iijima Y, Kawata H, Yamaguchi T, Uchida K, Eishi Y, Bando M, Hagiwara K. Propionibacterium acnes-associated sarcoidosis complicated by acute bird-related hypersensitivity pneumonitis. BMC Pulm Med 2020;20:288. [PMID: 33160347 DOI: 10.1186/s12890-020-01327-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
102 Huang YM, Lo C, Cheng CF, Lu CH, Hsieh SC, Li KJ. Serum C-Reactive Protein and Interleukin-6 Levels as Biomarkers for Disease Severity and Clinical Outcomes in Patients with Idiopathic Granulomatous Mastitis. J Clin Med 2021;10:2077. [PMID: 34066203 DOI: 10.3390/jcm10102077] [Reference Citation Analysis]
103 Saketkoo LA LA, Jensen K, Nikoletou D, Newton JJ, Rivera FJ, Howie M, Reese RK, Goodman M, Hart PB, Bembry W, Russell A, Lian I, Lammi MR, Scholand Mb MB, Russell Am AM. Sarcoidosis Illuminations on Living During COVID-19: Patient Experiences of Diagnosis, Management, and Survival Before and During the Pandemic. J Patient Exp 2022;9:23743735221075556. [PMID: 35350664 DOI: 10.1177/23743735221075556] [Reference Citation Analysis]
104 Wiener-Well Y, Levin PD, Sagi E, Ben-Chetrit E, Ben-Chetrit E. Caught Red-Handed. Arthritis Care Res (Hoboken) 2020. [PMID: 33278059 DOI: 10.1002/acr.24532] [Reference Citation Analysis]
105 Abrantes FF, Moraes MPM, Rezende Filho FM, Pedroso JL, Barsottini OGP. A clinical approach to hypertrophic pachymeningitis. Arq Neuropsiquiatr 2020;78:797-804. [PMID: 33295420 DOI: 10.1590/0004-282X20200073] [Reference Citation Analysis]
106 Frye BC, Potasso L, Farin-Glattacker E, Birring S, Müller-Quernheim J, Schupp JC. FeV1 and BMI influence King's Sarcoidosis Questionnaire score in sarcoidosis patients. BMC Pulm Med 2021;21:395. [PMID: 34861850 DOI: 10.1186/s12890-021-01761-7] [Reference Citation Analysis]
107 Kondle S, Hou T, Manansala M, Ascoli C, Novak RM, Sweiss N. Treatment of COVID-19 in Patients With Sarcoidosis. Front Med (Lausanne) 2021;8:689539. [PMID: 34336892 DOI: 10.3389/fmed.2021.689539] [Reference Citation Analysis]
108 Byg K, Illes Z, Sejbaek T, Lambertsen KL, Ellingsen T, Nielsen HH. Inflammatory profiles in plasma and cerebrospinal fluid of patients with neurosarcoidosis. Journal of Neuroimmunology 2022. [DOI: 10.1016/j.jneuroim.2022.577849] [Reference Citation Analysis]
109 Harada K, Hagiya H, Koyama T, Otsuka F. Trends in sarcoidosis mortality rate in Japan from 2001 to 2020: A population-based study. Respir Med 2022;196:106828. [PMID: 35349955 DOI: 10.1016/j.rmed.2022.106828] [Reference Citation Analysis]
110 Damsky W, Wang A, Kim DJ, Young BD, Singh K, Murphy MJ, Daccache J, Clark A, Ayasun R, Ryu C, McGeary MK, Odell ID, Fazzone-Chettiar R, Pucar D, Homer R, Gulati M, Miller EJ, Bosenberg M, Flavell RA, King B. Inhibition of type 1 immunity with tofacitinib is associated with marked improvement in longstanding sarcoidosis. Nat Commun 2022;13:3140. [PMID: 35668129 DOI: 10.1038/s41467-022-30615-x] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
111 Karakaya B, van Moorsel CHM, Veltkamp M, Roodenburg-Benschop C, Kazemier KM, van der Helm-van Mil AHM, Huizinga TWJ, Grutters JC, Rijkers GT. A Polymorphism in C-C Chemokine Receptor 5 (CCR5) Associates with Löfgren's Syndrome and Alters Receptor Expression as well as Functional Response. Cells 2021;10:1967. [PMID: 34440736 DOI: 10.3390/cells10081967] [Reference Citation Analysis]
112 Jastrzebski D, Toczylowska B, Zieminska E, Zebrowska A, Kostorz-Nosal S, Swietochowska E, Di Giulio C, Ziora D. The effects of exercise training on lipid profile in patients with sarcoidosis. Sci Rep 2021;11:5551. [PMID: 33692469 DOI: 10.1038/s41598-021-84815-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
113 Tana C, Drent M, Nunes H, Kouranos V, Cinetto F, Jessurun NT, Spagnolo P. Comorbidities of sarcoidosis. Ann Med 2022;54:1014-35. [PMID: 35441568 DOI: 10.1080/07853890.2022.2063375] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
114 Beijer E, Seldenrijk K, Meek B, Damen J, Quanjel MJR, Grutters JC, Veltkamp M. Detection of Cutibacterium acnes in granulomas of patients with either hypersensitivity pneumonitis or vasculitis reveals that its presence is not unique for sarcoidosis. ERJ Open Res 2021;7:00930-2020. [PMID: 34007840 DOI: 10.1183/23120541.00930-2020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
115 Zhao M, Tian C, Cong S, Di X, Wang K. From COVID-19 to Sarcoidosis: How Similar Are These Two Diseases? Front Immunol 2022;13:877303. [DOI: 10.3389/fimmu.2022.877303] [Reference Citation Analysis]
116 Muromoto R, Oritani K, Matsuda T. Current understanding of the role of tyrosine kinase 2 signaling in immune responses. World J Biol Chem 2022; 13(1): 1-14 [DOI: 10.4331/wjbc.v13.i1.1] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
117 Jeny F, Grutters JC. Experimental models of sarcoidosis: where are we now? Curr Opin Pulm Med 2020;26:554-61. [PMID: 32701674 DOI: 10.1097/MCP.0000000000000708] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
118 Starshinova AA, Malkova AM, Basantsova NY, Zinchenko YS, Kudryavtsev IV, Ershov GA, Soprun LA, Mayevskaya VA, Churilov LP, Yablonskiy PK. Sarcoidosis as an Autoimmune Disease. Front Immunol 2019;10:2933. [PMID: 31969879 DOI: 10.3389/fimmu.2019.02933] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 9.0] [Reference Citation Analysis]
119 Innabi A, Alzghoul BN, Kalra S, Al-Hakim T, Buchanan M, Shivas T, Xue W, Gomez-Manjarres D, Patel DC. Sarcoidosis among US Hispanics in a Nationwide Registry. Respir Med 2021;190:106682. [PMID: 34788736 DOI: 10.1016/j.rmed.2021.106682] [Reference Citation Analysis]